Affinity Asset Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-372,476
| Closed | -$790K | – | 64 |
|
|
2022
Q3 | $790K | Sell |
372,476
-94,131
| -20% | -$200K | 0.22% | 40 |
|
|
2022
Q2 | $1.26M | Sell |
466,607
-92,412
| -17% | -$249K | 0.53% | 26 |
|
|
2022
Q1 | $2.43M | Sell |
559,019
-490,702
| -47% | -$2.13M | 0.39% | 31 |
|
|
2021
Q4 | $5.44M | Buy |
1,049,721
+74,721
| +8% | +$387K | 1.97% | 19 |
|
|
2021
Q3 | $5.99M | Buy |
975,000
+75,000
| +8% | +$461K | 1.51% | 14 |
|
|
2021
Q2 | $9.09M | Buy |
900,000
+211,000
| +31% | +$2.13M | 3.25% | 4 |
|
|
2021
Q1 | $9.49M | Buy |
689,000
+389,000
| +130% | +$5.36M | 3.22% | 6 |
|
|
2020
Q4 | $3.26M | Buy |
+300,000
| New | +$3.26M | 1.73% | 14 |
|